In a small Boston study, hepatic steatosis was detected in 42% of HIV-infected patients and was associated with insulin resistance and visceral fat accumulation.
Hepatic steatosis, a potential cause of liver dysfunction, is associated with a range of conditions, including viral hepatitis, obesity, diabetes mellitus, and alcohol abuse. How common is it, though, in HIV-infected patients? To find out, investigators performed magnetic resonance spectroscopy (MRS) in 33 HIV-infected patients without known liver disease.
Fourteen patients (42%) were found to have hepatic steatosis (defined as liver-fat content ≥5% by MRS; only about 5% of HIV-negative adults at low risk for steatosis have more than this amount of liver fat by MRS). HIV-infected patients with hepatic steatosis had a significantly higher mean body-mass index, waist-to-hip ratio, visceral adipose tissue (VAT) area, and subcutaneous adipose ti…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)